Effects of Telmisartan and Candesartan on the Metabolism of Lipids and Glucose in Kidney Transplant Patients: A Prospective, Randomized Crossover Study

BACKGROUND: The risk of cardiovascular events remains after kidney transplantation (KT). Abnormal glucose metabolism and hyperlipidemia contribute partly to this risk. Among angiotensin II type-1 receptor blockers, telmisartan alone has been shown to ameliorate these effects on glucose and lipid met...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Transplant Direct
Главные авторы: Miura, Yoshifumi, Noguchi, Hiroshi, Okabe, Yasuhiro, Masutani, Kosuke, Tokunaga, Shoji, Nakamura, Masafumi
Формат: Artigo
Язык:Inglês
Опубликовано: Lippincott Williams & Wilkins 2019
Предметы:
Kidney Transplantation
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6415969/
https://ncbi.nlm.nih.gov/pubmed/30882027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000861
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы